Avanos Medical (AVNS) Inventory (2013 - 2026)

Avanos Medical (AVNS) has 14 years of Inventory data on file, last reported at $141.3 million in Q1 2026.

• For the quarter ending Q1 2026, Inventory rose 2.32% year-over-year to $141.3 million; the trailing twelve-month figure through Mar 2026 stood at $141.3 million (up 2.32% YoY), and the FY2025 full-year result was $148.0 million, up 6.63% from the prior year.
• Inventory retreated to $141.3 million in Q1 2026, from $148.0 million in the prior quarter.
• In the past five years, Inventory ranged from a high of $200.0 million in Q1 2023 to a low of $132.3 million in Q4 2022.
• A 5-year average of $157.1 million and a median of $156.6 million in 2023 frame the typical range for Inventory.
• Peak annual rise in Inventory reached 26.9% in 2023, while the deepest fall reached 19.11% in 2023.
• Tracing AVNS's Inventory over 5 years: stood at $132.3 million in 2022, then grew by 23.36% to $163.2 million in 2023, then declined by 14.95% to $138.8 million in 2024, then gained by 6.63% to $148.0 million in 2025, then dropped by 4.53% to $141.3 million in 2026.
• Business Quant data shows AVNS's Inventory at $141.3 million in Q1 2026, $148.0 million in Q4 2025, and $150.6 million in Q3 2025.